Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00541996 · ClinicalTrials.gov registry record · Phase 1
Study Comparing Bioavailability of Oral Formulations of Vabicaserin
A Phase 1 study, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00541996: Completed Phase 1 study, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.
NCT00541996 is a Phase 1 study that has completed, run by Wyeth is now a wholly owned subsidiary of Pfizer. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00541996, a Phase 1 study, has completed, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
The purpose of this study is to determine the absorption rate of four oral formulations of vabicaserin.
Interventions
- DRUG vabicaserin
Trial Details
| Field | Value |
|---|---|
| Start Date | 2007-08 |
| Est. Completion | 2007-10 |
| Phase | Phase 1 |
What the finished NCT00541996 record still lists
NCT00541996 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which vabicaserin is the first listed.
NCT00541996 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00541996 about?
NCT00541996 is a clinical study titled "Study Comparing Bioavailability of Oral Formulations of Vabicaserin". The purpose of this study is to determine the absorption rate of four oral formulations of vabicaserin.
What is the current status of trial NCT00541996?
This trial is currently completed. It is a Phase 1 study. The study started on 2007-08. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00541996?
The interventions under investigation include: vabicaserin (DRUG).
Who is sponsoring clinical trial NCT00541996?
This trial is sponsored by Wyeth is now a wholly owned subsidiary of Pfizer, which has 167 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia